GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company ...

Jan 6 (Reuters) - STAAR Surgical (STAA.O), opens new tab said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon (ALCC.S), opens new tab after failing to secure ...

Shareholders of Staar Surgical, a manufacturer of the Implantable Collamer Lens, have likely definitively voted against Alcon’s $1.6 billion buyout offer. Broadwood Partners, which holds 30.2% of ...

Alcon Inc., the Swiss eye-care specialist, got its first bearish mark from analysts since August after Bank of America Corp. double downgraded the stock, warning that a slower rollout of its new ...

In August, the eye care company Alcon agreed to acquire STAAR Surgical, the manufacturer of the implantable collamer lens, for a total equity value of approximately $1.5 billion. On Tuesday, Alcon ...

Dec 9 (Reuters) - Swiss eyecare giant Alcon (ALCC.S), opens new tab has made a new offer for Staar Surgical (STAA.O), opens new tab worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal ...

Alcon ALC-0.55%decrease; red down pointing triangle shares in Switzerland rose after the eye-care specialist reported an acceleration in third-quarter sales growth and confirmed its annual outlook, ...

In August, Geneva, Switzerland-based eye care company Alcon agreed to buy Staar Surgical in a deal valued at $1.5 billion, but STAAR has faced opposition to the deal, including from its largest ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Alcon, already one of the ...